MMP2 and glioblastoma: The results demonstrated that SynB3‐PVGLIG‐PTX had the lowest binding free energy with MMP‐2, revealing that SynB3‐PVGLIG‐PTX could be specifically recognized and cleaved by MMP‐2 and also suggesting its potential value as a drug delivery system for GBM therapy.